Clinical Trial Update: Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL [Phase 1, Phase 2]

View source ↗

Summary

A sequential CD19 and CD22 CAR-T therapy approach is being evaluated in newly diagnosed Ph- B-ALL in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia Adult

Drugs mentioned

• CD19 CAR-T therapy (CD19-targeted CAR-T cell therapy)
• CD22 CAR T therapy (CD22 CAR T)

Snippet

Sponsor: Zhejiang University | Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult | Phase 1, Phase 2 | Status: UNKNOWN